Dear Reader, If you're looking for a great AI stock under $10... you need to watch this right away. What the company is doing is pretty incredible. It could end up saving billions of lives... and billions of dollars. In short, the company is the creator of the first AI-designed drug to enter clinical trials. And this is a huge deal. Normally, bringing a new drug to market takes an average of 10 years and between $2.5 and $12 billion. However, new AI technology has the potential to make the process up to 1000 times faster. The Wall Street Journal reports that "the time required for the early stages of drug discovery could shrink from years to months." Not only that, it has the potential to develop "never-before-seen molecules that could treat diseases like pancreatic cancer or ALS." In short, this is groundbreaking stuff. And this #1 AI company is at the forefront of all of it. The biggest pharmaceutical companies in the world are lining up to work with them. For example...
In other words, these deals have the potential to drive the stock many times higher in the months and years ahead. So again, if you're looking for a great AI stock to own, you need to watch this presentation right away. P.S. The best way to play this AI stock involves an investment strategy used by a Kansas welder to become one of the wealthiest people in the world. See his incredible investment approach here. Sincerely, Rachel Gearhart Publisher, The Oxford Club This ad is sent on behalf of The Oxford Club, 105 W. Monument Street Baltimore, MD 21201. If you would like to opt out from receiving offers from The Oxford Club, please click here This is a PAID ADVERTISEMENT provided to the subscribers of StockEarnings Free Newsletter. Although we have sent you this email, StockEarnings does not specifically endorse this product nor is it responsible for the content of this advertisement. Furthermore, we make no guarantee or warranty about what is advertised above. Your privacy is very important to us, if you wish to be excluded from future notices, do not reply to this message. Instead, please click Unsubscribe . StockEarnings, Inc |
Today's Bonus Content: Jeff Bezos backs tiny biotech with $130 mil investment
No comments:
Post a Comment